Banwell CM et al. |
Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. |
2004 |
J. Steroid Biochem. Mol. Biol. |
pmid:15225779
|
Fang JY et al. |
Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116. |
2004 |
Cell Res. |
pmid:15225415
|
Sumer H et al. |
Effects of scaffold/matrix alteration on centromeric function and gene expression. |
2004 |
J. Biol. Chem. |
pmid:15220334
|
Jia S et al. |
RNAi-independent heterochromatin nucleation by the stress-activated ATF/CREB family proteins. |
2004 |
Science |
pmid:15218150
|
Ishihara K et al. |
Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. |
2004 |
Br. J. Pharmacol. |
pmid:15210580
|
Korzus E et al. |
CBP histone acetyltransferase activity is a critical component of memory consolidation. |
2004 |
Neuron |
pmid:15207240
|
Min KN et al. |
Estrogen receptor enhances the antiproliferative effects of trichostatin A and HC-toxin in human breast cancer cells. |
2004 |
Arch. Pharm. Res. |
pmid:15202563
|
Moldenhauer A et al. |
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins. |
2004 |
J. Leukoc. Biol. |
pmid:15197237
|
Lu H et al. |
Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat. |
2004 |
J. Virol. |
pmid:15194748
|
Ng Y et al. |
Expression of the human myotonic dystrophy kinase-related Cdc42-binding kinase gamma is regulated by promoter DNA methylation and Sp1 binding. |
2004 |
J. Biol. Chem. |
pmid:15194684
|
Sakamoto S et al. |
Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. |
2004 |
J. Biol. Chem. |
pmid:15194680
|
Brieger A et al. |
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors. |
2004 |
Biochem. Pharmacol. |
pmid:15183120
|
Ishiguro K and Sartorelli AC |
Activation of transiently transfected reporter genes in 3T3 Swiss cells by the inducers of differentiation/apoptosis--dimethylsulfoxide, hexamethylene bisacetamide and trichostatin A. |
2004 |
Eur. J. Biochem. |
pmid:15182353
|
Vanhaecke T et al. |
Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. |
2004 |
Curr. Med. Chem. |
pmid:15180568
|
Ahn MR et al. |
Trichostatin A, a histone deacetylase inhibitor stimulate CYP3A4 proximal promoter activity in Hepa-I cells. |
2004 |
Arch. Pharm. Res. |
pmid:15180307
|
Flørenes VA et al. |
Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival. |
2004 |
Melanoma Res. |
pmid:15179185
|
Lee YJ et al. |
Mechanism of transcriptional repression by TEL/RUNX1 fusion protein. |
2004 |
Mol. Cells |
pmid:15179033
|
Zhang X et al. |
Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3. |
2004 |
Mol. Cell. Biol. |
pmid:15169878
|
Ronai D et al. |
The epigenetic stability of the locus control region-deficient IgH locus in mouse hybridoma cells is a clonally varying, heritable feature. |
2004 |
Genetics |
pmid:15166165
|
Glenn MP et al. |
Antiproliferative and phenotype-transforming antitumor agents derived from cysteine. |
2004 |
J. Med. Chem. |
pmid:15163181
|
Zhang Y et al. |
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. |
2004 |
Radiat. Res. |
pmid:15161353
|
Wang LG et al. |
Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. |
2004 |
Oncogene |
pmid:15156193
|
Zoumpoulidou G et al. |
Convergence of interferon-gamma and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y). |
2004 |
Mol. Endocrinol. |
pmid:15155784
|
Kato N et al. |
Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines. |
2004 |
Cell Death Differ. |
pmid:15153943
|
Kim YH et al. |
Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. |
2004 |
Carcinogenesis |
pmid:15142888
|
Kurtev V et al. |
Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. |
2004 |
J. Biol. Chem. |
pmid:15140878
|
Jin YH et al. |
Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. |
2004 |
J. Biol. Chem. |
pmid:15138260
|
Winn RA and Heasley LE |
Gamma-catenin expression is reduced or absent in a subset of human non-small cell lung cancers, and its re-expression inhibits cell growth. |
2004 |
Chest |
pmid:15136458
|
Ishii S et al. |
Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone. |
2004 |
Mol. Endocrinol. |
pmid:15131262
|
Bort R et al. |
Role of hepatocyte nuclear factor 3 gamma in the expression of human CYP2C genes. |
2004 |
Arch. Biochem. Biophys. |
pmid:15130783
|
Iezzi S et al. |
Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. |
2004 |
Dev. Cell |
pmid:15130492
|
Phan D et al. |
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. |
2004 |
Cancer Res. |
pmid:15126343
|
Fu M et al. |
The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. |
2004 |
J. Biol. Chem. |
pmid:15123687
|
Klampfer L et al. |
Requirement of histone deacetylase activity for signaling by STAT1. |
2004 |
J. Biol. Chem. |
pmid:15123634
|
Mizukami T et al. |
Effects of trichostatin a, a histone deacetylase inhibitor, on mouse gonadal development in vitro. |
2004 |
J. Reprod. Dev. |
pmid:15118250
|
Arapshian A et al. |
Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer. |
2004 |
Mol. Cancer |
pmid:15113415
|
Marson CM et al. |
Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15109636
|
Nishino N et al. |
Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:15109626
|
McGarry LC et al. |
Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. |
2004 |
Oncogene |
pmid:15107823
|
Yokota T et al. |
Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. |
2004 |
Oncogene |
pmid:15107822
|
Lasa A et al. |
MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias. |
2004 |
Leukemia |
pmid:15103390
|
Jansen MS et al. |
Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15103026
|
Tani M et al. |
Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells. |
2004 |
Genes Chromosomes Cancer |
pmid:15101048
|
Munro J et al. |
Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. |
2004 |
Exp. Cell Res. |
pmid:15093749
|
Chang HC et al. |
Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. |
2004 |
Cell. Signal. |
pmid:15093608
|
Milutinovic S et al. |
DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. |
2004 |
J. Biol. Chem. |
pmid:15087453
|
Amor DJ et al. |
Human centromere repositioning "in progress". |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:15084747
|
Ahmed S et al. |
A novel protein with similarities to Rb binding protein 2 compensates for loss of Chk1 function and affects histone modification in fission yeast. |
2004 |
Mol. Cell. Biol. |
pmid:15082762
|
Romanski A et al. |
Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia. |
2004 |
Haematologica |
pmid:15075075
|
Margueron R et al. |
Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens. |
2004 |
J. Mol. Endocrinol. |
pmid:15072561
|
Ganslmayer M et al. |
A quadruple therapy synergistically blocks proliferation and promotes apoptosis of hepatoma cells. |
2004 |
Oncol. Rep. |
pmid:15069530
|
Tong X et al. |
Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15063780
|
Vorontsova M et al. |
Effect of 5-azacytidine and trichostatin A on somatic centromere association in wheat. |
2004 |
Genome |
pmid:15060593
|
Hildmann C et al. |
A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylases. |
2004 |
J. Bacteriol. |
pmid:15060035
|
Chen YX et al. |
[Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines]. |
2004 |
Zhonghua Yi Xue Za Zhi |
pmid:15059516
|
Kypreou KP et al. |
Age-dependent response of lymphocytes in the induction of the linker histone variant, H1 degrees and histone H4 acetylation after treatment with the histone deacetylase inhibitor, trichostatin A. |
2004 |
Exp. Gerontol. |
pmid:15050280
|
Steiner E et al. |
SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15047174
|
Liu X et al. |
Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone. |
2004 |
Biochem. Pharmacol. |
pmid:15041467
|
David GL et al. |
MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine. |
2004 |
Cancer Biol. Ther. |
pmid:15034303
|
Burton GR et al. |
Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis. |
2004 |
Gene |
pmid:15033539
|
Chung YL et al. |
Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. |
2004 |
Mol. Cancer Ther. |
pmid:15026552
|
Knobbe CB et al. |
Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas. |
2004 |
J. Natl. Cancer Inst. |
pmid:15026474
|
Aapola U et al. |
Epigenetic modifications affect Dnmt3L expression. |
2004 |
Biochem. J. |
pmid:15015937
|
Huang H et al. |
Expression of P53, P21 in human lung adenocarcinoma A549 cell strains under hypoxia conditions and the effect of TSA on their expression. |
2003 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:15015635
|
Gray SG et al. |
Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines. |
2004 |
Int. J. Oncol. |
pmid:15010814
|
Astrand C et al. |
Trichostatin A reduces hormone-induced transcription of the MMTV promoter and has pleiotropic effects on its chromatin structure. |
2004 |
Eur. J. Biochem. |
pmid:15009194
|
Hwang CK et al. |
Transcriptional regulation of mouse mu opioid receptor gene by PU.1. |
2004 |
J. Biol. Chem. |
pmid:14998994
|
Ragno R et al. |
3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies. |
2004 |
J. Med. Chem. |
pmid:14998325
|
Khan AN et al. |
An epigenetically altered tumor cell vaccine. |
2004 |
Cancer Immunol. Immunother. |
pmid:14997346
|
Chua YL et al. |
Microarray analysis of chromatin-immunoprecipitated DNA identifies specific regions of tobacco genes associated with acetylated histones. |
2004 |
Plant J. |
pmid:14996214
|
Nojima H et al. |
Increase in DNA methylation downregulates conceptus interferon-tau gene expression. |
2004 |
Mol. Reprod. Dev. |
pmid:14991730
|
Lu XC et al. |
[Effect of inhibitors for demethylation and histone deacetylase on proliferation of cell line K562 and expression of tumor related genes]. |
2004 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:14989767
|
Sakata R et al. |
Trichostatin A activates the osteopontin gene promoter through AP1 site. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:14985105
|
Agostinho M et al. |
Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis. |
2004 |
Mol. Biol. Cell |
pmid:14978217
|
Milhem M et al. |
Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A. |
2004 |
Blood |
pmid:14976039
|
Mai A et al. |
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity. |
2004 |
J. Med. Chem. |
pmid:14971890
|
Reifenberger J et al. |
Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. |
2004 |
Int. J. Cancer |
pmid:14961576
|
Takai N et al. |
Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. |
2004 |
Clin. Cancer Res. |
pmid:14871994
|
GarcÃa I et al. |
Chromatin rearrangements in the prnD-prnB bidirectional promoter: dependence on transcription factors. |
2004 |
Eukaryotic Cell |
pmid:14871945
|
Um SJ et al. |
In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group. |
2004 |
Oncol. Rep. |
pmid:14767528
|
Hattori N et al. |
Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. |
2004 |
J. Biol. Chem. |
pmid:14761969
|
Lemonde S et al. |
Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene. |
2004 |
J. Neurochem. |
pmid:14756806
|
Lee JH et al. |
Histone deacetylase activity is required for embryonic stem cell differentiation. |
2004 |
Genesis |
pmid:14755802
|
Parekh-Olmedo H et al. |
The effect of hydroxyurea and trichostatin a on targeted nucleotide exchange in yeast and Mammalian cells. |
2003 |
Ann. N. Y. Acad. Sci. |
pmid:14751821
|
Wang DF et al. |
QSAR studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:14741273
|
Nishikawa J et al. |
Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line. |
2004 |
Virus Genes |
pmid:14739656
|
Christian M et al. |
Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. |
2004 |
J. Biol. Chem. |
pmid:14736873
|
Sugimoto S et al. |
Expression and regulation of tumor suppressor gene maspin in human bladder cancer. |
2004 |
Cancer Lett. |
pmid:14732229
|
Yan C et al. |
A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression. |
2004 |
FASEB J. |
pmid:14715692
|
Pagans S et al. |
Repression by TTK69 of GAGA-mediated activation occurs in the absence of TTK69 binding to DNA and solely requires the contribution of the POZ/BTB domain of TTK69. |
2004 |
J. Biol. Chem. |
pmid:14701830
|
Haggarty SJ et al. |
Small molecule modulation of the human chromatid decatenation checkpoint. |
2003 |
Chem. Biol. |
pmid:14700634
|
Leu TH et al. |
Participation of p97Eps8 in Src-mediated transformation. |
2004 |
J. Biol. Chem. |
pmid:14699156
|
Terui T et al. |
Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. |
2003 |
Cancer Res. |
pmid:14695212
|
Obata T et al. |
Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. |
2003 |
Clin. Cancer Res. |
pmid:14695142
|
Nambu Y et al. |
Transcription-coupled events associating with immunoglobulin switch region chromatin. |
2003 |
Science |
pmid:14684824
|
Vaisburg A et al. |
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitors. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:14684344
|
Jang ER et al. |
The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor alpha-negative breast cancer cells to tamoxifen. |
2004 |
Oncogene |
pmid:14676837
|
Brush MH et al. |
Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. |
2004 |
J. Biol. Chem. |
pmid:14670976
|
Kim DK et al. |
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors. |
2003 |
J. Med. Chem. |
pmid:14667227
|
Shim JS et al. |
Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. |
2004 |
Oncogene |
pmid:14661058
|